LINQ II Insertable Cardiac Monitor vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Mycardium AI Limited

AI Verdict

These two tools are adjacent in the broader field of Cardiology AI but serve distinct purposes. Tool A, the LINQ II Insertable Cardiac Monitor, focuses on long-term, continuous heart rhythm monitoring and arrhythmia detection using an implantable device. In contrast, Tool B, 1CMR Pro, is software designed to enhance the speed and precision of Cardiac MRI reporting through AI-driven image analysis.

Choose LINQ II Insertable Cardiac Monitor if…

Choose LINQ II if your primary need is long-term, continuous, and highly accurate monitoring of heart rhythms for the diagnosis of infrequent or paroxysmal arrhythmias. This tool is ideal for patients experiencing unexplained syncope, cryptogenic stroke, or those requiring extended monitoring for conditions like atrial fibrillation, leveraging AI for enhanced detection and remote management capabilities.

View LINQ II Insertable Cardiac Monitor →

Choose 1CMR Pro if…

Choose 1CMR Pro if your institution requires an AI-enhanced solution to significantly improve the speed, precision, and consistency of cardiac MRI reporting and analysis. This software is best suited for radiology and cardiology departments aiming to automate volumetric and functional measurements, ensuring regulatory-grade accuracy and local data processing for enhanced security and workflow efficiency.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor 1CMR Pro
Pricing Unknown Contact for pricing
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Tool A (LINQ II) offers a patient-facing mobile app and remote programming capabilities, enhancing usability for both patients and clinicians in managing the device and data. Tool B focuses on clinician-controlled software for MRI analysis, without explicit mention of patient-facing or remote access features for clinicians.

Clinical Value

1CMR Pro

Tool B (1CMR Pro) provides a quantifiable and significant improvement in cardiac MRI analysis, achieving up to 40% higher precision and consistency in measurements through advanced AI, validated across multi-center datasets. While Tool A offers valuable long-term arrhythmia monitoring, Tool B's specific, measurable enhancement in a critical diagnostic imaging modality gives it an edge in this dimension.

Pricing & Value

Tie

Both tools operate on an enterprise pricing model with no public disclosure or free trial options. Without transparent pricing information, it is impossible to determine which offers better value.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Tool A (Medtronic LINQ II) benefits from being offered by a large, established global medical device company with a proven track record, extensive customer base (over 1 million patients), explicit HIPAA compliance, and FDA clearance. Tool B, while cleared by regulatory bodies and offering secure local data processing, comes from a smaller company with less publicly documented enterprise experience.

Innovation

1CMR Pro

Tool B (1CMR Pro) demonstrates significant innovation by leveraging advanced convolutional neural networks trained on massive datasets to achieve regulatory-grade automation and up to 40% higher precision in complex cardiac MRI analysis. While Tool A's integration of AI into an insertable device with remote capabilities is innovative, Tool B's quantifiable leap in diagnostic imaging precision stands out.

Support & Docs

LINQ II Insertable Cardiac Monitor

Tool A (Medtronic LINQ II) is backed by Medtronic, a large, established medical device company with a long history of providing extensive support, documentation, and resources for its products to both clinicians and patients. Tool B, from a smaller, specialized AI company, does not have readily apparent comprehensive support resources publicly available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor 1CMR Pro
Tool Name LINQ II Insertable Cardiac Monitor 1CMR Pro
Company Medtronic Mycardium AI Limited
Primary Function Long-term, continuous heart rhythm monitoring for diagnosing arrhythmias. AI-enhanced Cardiac MRI reporting software for faster and more consistent cardiac MRI analysis.
Key AI Capability AccuRhythmu2122 AI algorithms for enhanced accuracy, innovative PVC detection algorithm. AI-enhanced Cardiac MRI Reporting, Automated volumetric and functional measurements, Convolutional neural networks trained on extensive datasets.
Data Processing Location MyCareLink Heartu2122 mobile app for data transmission, MyCareLink Relayu2122 home communicator option (implies remote transmission). Local data processing (no patient data transmitted beyond institution).
Monitoring/Analysis Duration Up to 4.5 years of continuous monitoring. Not specified
Specialties Cardiology Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and 1CMR Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and diagnosing arrhythmias. In contrast, 1CMR Pro by Mycardium AI is an AI-enhanced software for cardiac MRI reporting, focusing on analysis and measurements.
The LINQ II utilizes AccuRhythmu2122 AI algorithms for enhanced accuracy in detecting arrhythmias and includes an innovative PVC detection algorithm. 1CMR Pro employs convolutional neural networks, trained on extensive datasets, to provide AI-enhanced cardiac MRI reporting and automated volumetric and functional measurements.
The LINQ II uses the MyCareLink Heartu2122 mobile app for data transmission and offers a MyCareLink Relayu2122 home communicator option. 1CMR Pro emphasizes local data processing, meaning no patient data is transmitted beyond the institution, and it is deployed as on-premise software.
The LINQ II highlights 'AI-powered accuracy' and 'enhanced accuracy' for diagnosing arrhythmias. 1CMR Pro claims to deliver up to 40% more precise measurements and offers regulatory-grade automation for enhanced precision and reproducibility in cardiac MRI analysis.
The Medtronic LINQ II has a pediatric indication for ages 2 and older and is MRI compatible (1.5 and 3.0T). While 1CMR Pro is for cardiac MRI reporting, the LINQ II explicitly states its device's compatibility with MRI scanners.
AI Tool Finder
AI-powered search. Results may not be comprehensive.